Price $37.36 |
Market Cap
10.83B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
14.4
|
P/B
3.77
|
P/S
3.63
|
Dividend %
-
|
|
P/CF
72.5
|
P/FCF
260.8
|
Op. Cash Flow
59.2K
|
FCF
0.1
|
|
Op. Margin
47.10%
|
Net Margin
25.60%
|
ROE
30.50%
|
ROI
8.40%
|
|
ROA
9.70%
|
EPS Growth
191.40%
|
Current Ratio
1.5
|
Debt/Equity
142.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| AdvanSource Biomaterials Corpo (ASNB) | $0.10 | - | - | 1.6M | Strong Buy |
| American Renal Associates Hold (ARA) | $14.13 | - | - | 448.3M | Strong Buy |
| Palatin Technologies, Inc. (PTN) | $0.60 | - | - | 65.7M | Strong Buy |
| AMAG Pharmaceuticals, Inc. (AMAG) | $18.45 | - | - | 589.3M | Strong Buy |
| iCAD Inc (ICAD) | $3.56 | - | - | 65.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
